News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,346 Results
Type
Article (168)
Company Profile (1)
Press Release (1177)
Section
Business (518)
Career Advice (3)
Deals (112)
Drug Delivery (23)
Drug Development (177)
Employer Resources (1)
FDA (31)
Job Trends (31)
News (761)
Policy (63)
Tag
Academia (2)
Accelerated approval (1)
Alliances (89)
Alzheimer's disease (2)
Antibody-drug conjugate (ADC) (4)
Approvals (26)
Artificial intelligence (1)
Bankruptcy (2)
Best Places to Work (9)
Bladder cancer (2)
Cancer (19)
Cardiovascular disease (4)
Career advice (4)
CAR-T (1)
Cell therapy (4)
Clinical research (122)
Collaboration (6)
Complete response letters (5)
COVID-19 (18)
C-suite (12)
Data (9)
Diabetes (13)
Diagnostics (4)
Drug discovery (2)
Drug pricing (1)
Drug shortages (9)
Earnings (190)
Editorial (4)
Employer resources (1)
Events (167)
Executive appointments (6)
FDA (37)
Fibrodysplasia Ossificans Progressiva (1)
Funding (1)
Gene therapy (4)
GLP-1 (39)
Government (17)
Guidances (1)
Healthcare (30)
Immunology and inflammation (2)
Indications (1)
Infectious disease (18)
IPO (46)
Job creations (17)
Job search strategy (3)
JPM (1)
Layoffs (7)
Legal (6)
Lung cancer (4)
Lymphoma (1)
Management (1)
Manufacturing (51)
Medical device (10)
Medtech (10)
Mergers & acquisitions (83)
Metabolic disorders (37)
mRNA (2)
Multiple sclerosis (1)
Neurodegenerative disease (3)
Neuroscience (9)
NextGen: Class of 2026 (9)
Non-profit (1)
Obesity (30)
Opinion (3)
Pancreatic cancer (1)
Parkinson's disease (2)
Patient recruitment (4)
People (221)
Phase 1 (40)
Phase 2 (50)
Phase 3 (69)
Pipeline (26)
Policy (2)
Preclinical (14)
Rare diseases (5)
Real estate (16)
Regulatory (74)
Research institute (3)
Spinal muscular atrophy (3)
Startups (6)
Supply chain (11)
The Weekly (5)
Vaccines (1)
Venture capital (3)
Weight loss (36)
Date
Last 7 days (3)
Last 30 days (10)
Last 365 days (95)
2026 (35)
2025 (90)
2024 (119)
2023 (83)
2022 (148)
2021 (142)
2020 (146)
2019 (94)
2018 (65)
2017 (71)
2016 (55)
2015 (55)
2014 (34)
2013 (37)
2012 (61)
2011 (30)
2010 (25)
Location
Africa (4)
Asia (32)
Australia (6)
California (15)
Canada (4)
China (2)
Connecticut (1)
Delaware (2)
Europe (171)
Florida (10)
India (1)
Indiana (3)
Maryland (2)
Massachusetts (13)
Michigan (3)
Minnesota (1)
New Jersey (13)
New York (13)
North Carolina (7)
Northern California (12)
Pennsylvania (1)
South America (3)
Southern California (1)
Tennessee (3)
Texas (2)
United States (90)
Washington D.C. (1)
Wisconsin (2)
1,346 Results for "catalent".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cartherics and Catalent Expand Commercial License Agreement
April 10, 2026
·
4 min read
Complete response letters
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did not flag problems with the drug’s efficacy or safety.
March 9, 2026
·
2 min read
·
Tristan Manalac
Layoffs
Layoffs at Novo’s Ex-Catalent Site Despite Signs of Turnaround, Continued Investment
As Novo Nordisk cuts 400 jobs at the troubled site, Scholar Rock has seen enough progress that it included the facility in a resubmission for FDA approval.
April 1, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Catalent and S.Biomedics Announce Partnership to Develop and Manufacture TED‑A9
February 18, 2026
·
3 min read
Press Releases
Catalent and GelMEDIX Enter Global Partnership for the Development and Clinical Manufacturing of iPSC-Derived Cell Therapies in Ocular and Retinal Diseases
March 11, 2026
·
3 min read
Press Releases
SmartCella and Catalent Sign Nonexclusive License Agreement for GMP iPSCs
January 12, 2026
·
3 min read
Press Releases
Catalent’s SMARTag® ADC Pipeline and New Enhanced Conjugates Offering Featured at 16th World ADC San Diego
November 4, 2025
·
4 min read
Deals
Amid Novo Buy, Catalent Offloads New Jersey Facility to Ardena
European CDMO Ardena will buy Catalent’s oral solids manufacturing facility in Somerset, N.J.
October 14, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement
October 9, 2025
·
8 min read
Editorial
Lilly vs. Novo: The ‘He Said, She Said’ Row About Catalent’s GLP-1 Work
With Novo Holdings’ $16.5 billion buyout of Catalent being reviewed by regulators, what work the contract drug manufacturer may or may not be performing for Eli Lilly remains a point of contention.
November 8, 2024
·
4 min read
·
Greg Slabodkin
1 of 135
Next
